Pharma

By Dave Muoio April 19, 2018
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler. Launched in 2016, the web- and mobile-based RespiPoints program offers patients a variety of adherence-...
By Babyforyou.net.ua April 13, 2018
Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception. With the exception of some medication adherence-focused technologies — such as an edible QR code intended to assist with medication dosing — news tended to center around digitally-enabled clinical trials, rollouts or pilots of pharma-focused digital tools, and major deals or...
By Dave Muoio April 12, 2018
ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the...
By Susan Morse April 4, 2018
Five healthcare organizations including insurers UnitedHealthcare and Humana, Optum, Quest Diagnostics, and MultiPlan are launching a blockchain pilot to help payers tackle mandated provider directories. UnitedHealthcare and Optum are both part of UnitedHealth Group. Humana got involved through old-fashioned networking, according to Mike Jacobs, a senior distinguished engineer at Optum, who has...
By Dave Muoio April 4, 2018
Pfizer announced today that it is receiving applications for its Pfizer Healthcare Hub: London competitive grant. This is the second time that Pfizer has held the startup-focused program, which representatives from biopharmaceutical company said had a strong inaugural year in 2017. “Following the success of the 2017 UK Hub, I’m delighted to continue the program again this year,” Erik Nordkamp,...
By Jonah Comstock April 3, 2018
Walmart is reportedly in talks to acquire PillPack, a New England-based virtual pharmacy with around $100 million in funding. According to CNBC, which broke the news, the retail giant is offering less than $1 billion for the startup. But the deal could still fall apart, CNBC's sources said. Founded in 2013, PillPack offers a virtual pharmacy experience for people who can't or would rather not...
By Jonah Comstock March 16, 2018
Platinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers. Platinum Equity will pay $2.1 billion for the business, which reported $1.5...
By Jonah Comstock March 12, 2018
Digital therapeutics may be up and coming, but they also have a long way to go before their mainstream treatment options, according to experts who spoke at the digital therapeutics deep dive at HIMSS18. “This is going to be a completely new industry sector,” Pierre Leurent, CEO of Voluntis, said during the session. “It’s going to have very strong growth in the years to come and it’s going to be a...
By Laura Lovett March 2, 2018
Artificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health Oncology, that uses EMR data to provide practical AI applications for real oncology use cases.  “Our team of healthcare professionals is using the deep clinical oncology dataset at...
By Jonah Comstock March 1, 2018
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia. It’s the first time a pharma company has made a development deal with a digital therapeutic, according to Pear. “We have been in discussions for many months now with the [Novartis Institutes for BioMedical Research] group at...

Editor's Pick